Do we want a Synthetic or Cross- sectional population approach to simulation modeling?

Slides:



Advertisements
Similar presentations
How would you explain the smoking paradox. Smokers fair better after an infarction in hospital than non-smokers. This apparently disagrees with the view.
Advertisements

Multiple Indicator Cluster Surveys Data Interpretation, Further Analysis and Dissemination Workshop Basic Concepts of Further Analysis.
Home Ownership and Equity in the Canadian LifePaths Model IMA 2011
Designing Clinical Research Studies An overview S.F. O’Brien.
Research Designs Commonly Used In Epidemiology. One of the basic concepts in research designs which are trying to discern cause is that we have to make.
Study Designs in Epidemiologic
CONCEPTS UNDERLYING STUDY DESIGN
OVERVIEW OF STUDY DESIGN. COMMUNITY SURVEYS Nigel Paneth.
Case-Control Studies (Retrospective Studies). What is a cohort?
Observational Studies Based on Rosenbaum (2002) David Madigan Rosenbaum, P.R. (2002). Observational Studies (2 nd edition). Springer.
Recent Research on Immigrant Health from Statistics Canada’s Population Surveys Jennifer Ali Statistics Canada.
COMPAS Health micro-simulation model Québec, Canada Pierre-Carl Michaud, ESG UQAM.
Goodness of Fit of a Joint Model for Event Time and Nonignorable Missing Longitudinal Quality of Life Data – A Study by Sneh Gulati* *with Jean-Francois.
We’re ready to TEST our Research Questions! In science, how do we usually test a hypothesis?
1 Business 90: Business Statistics Professor David Mease Sec 03, T R 7:30-8:45AM BBC 204 Lecture 24 = Start Chapter “Fundamentals of Hypothesis Testing:
The Relationship Between Weight Status During Early Adulthood And Successful Aging In Elderly Canadian Males: The Manitoba Follow-up Study Dennis J. Bayomi,
Cohort Studies.
Measures of disease frequency (I). MEASURES OF DISEASE FREQUENCY Absolute measures of disease frequency: –Incidence –Prevalence –Odds Measures of association:
Selection of Data Sources for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Validation of predictive regression models Ewout W. Steyerberg, PhD Clinical epidemiologist Frank E. Harrell, PhD Biostatistician.
Introduction to Experimental and Observational Study Design KNNL – Chapter 16.
Chapter 2 Prevalence, incidence and natural history.
Body Mass Index, Weight Change and Death in an Older Hypertensive Population: The SHEP Study Grant W Somes Stephen B Kritchevsky Marco Pahor Ronald I Shorr.
Population Health Model (POHEM)
HSTAT1101: 27. oktober 2004 Odd Aalen
The healthy immigrant effect in Canada: a longitudinal perspective using National Population Health Surveys Edward Ng (a), Russell Wilkins, (a, b) and.
Multiple Choice Questions for discussion
1 Population Health Model (POHEM) AMI Acknowledgements: CCORT for collaboration and funding.
Dr. Abdulaziz BinSaeed & Dr. Hayfaa A. Wahabi Department of Family & Community medicine  Case-Control Studies.
 Be familiar with the types of research study designs  Be aware of the advantages, disadvantages, and uses of the various research design types  Recognize.
Criteria for Assessment of Performance of Cancer Risk Prediction Models: Overview Ruth Pfeiffer Cancer Risk Prediction Workshop, May 21, 2004 Division.
1 1 Seminar on POHEM – Tables Philippe Finès September 2011.
Health Statistics Information on STC website Calgary–DLI training–Dec 2003 Michel B. Séguin, Statistics Canada,
Behnam Sharif Star team trainee Webinar APRIL
Chapter 16 Conducting & Reading Research Baumgartner et al Chapter 16 Developing the Research Proposal.
Study Designs in Epidemiologic
Predicting risk of cardiovascular disease and the cost-effectiveness of interventions in Thailand Stephen Lim On Behalf of the Setting Priorities using.
What is Development? Systematic changes and continuities –In the individual –Between conception and death “Womb to Tomb” Three broad domains –Physical,
Epidemiological Study designs
Various topics Petter Mostad Overview Epidemiology Study types / data types Econometrics Time series data More about sampling –Estimation.
Agenda Introduction Model purpose Overall plan Schema Discussion Next Steps.
Lecture 7 Objective 18. Describe the elements of design of observational studies: case ‑ control studies (retrospective studies). Discuss the advantages.
Evaluating Transportation Impacts of Forecast Demographic Scenarios Using Population Synthesis and Data Simulation Joshua Auld Kouros Mohammadian Taha.
LEADING RESEARCH… MEASURES THAT COUNT Challenges of Studying Cardiovascular Outcomes in ADHD Elizabeth B. Andrews, MPH, PhD, VP, Pharmacoepidemiology and.
Types of study designs.
1 Risk Assessment Tests Marina Kondratovich, Ph.D. OIVD/CDRH/FDA March 9, 2011 Molecular and Clinical Genetics Panel for Direct-to-Consumer (DTC) Genetic.
Supporting Vascular Risk Assessment: QDScore Julia Hippisley-Cox 15 th April 2010.
WP 2:Future disease patterns and their implications for disability in later life C. Jagger, R. Matthews, J. Lindesay Leicester Nuffield Research Unit.
1 Lecture 6: Descriptive follow-up studies Natural history of disease and prognosis Survival analysis: Kaplan-Meier survival curves Cox proportional hazards.
An assessment of methods to impute risk exposure into model actor’s risk profile for microsimulation. Deirdre Hennessy and Claude Nadeau STAR webinar September.
Screening of diseases Dr Zhian S Ramzi Screening 1 Dr. Zhian S Ramzi.
Overview of Study Designs. Study Designs Experimental Randomized Controlled Trial Group Randomized Trial Observational Descriptive Analytical Cross-sectional.
Psy 311: Methods1 GOALS OF DEVELOPMENTAL PSYCHOLOGY l Describe, explain, and optimize human development.
Unit 15: Screening. Unit 15 Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
Research and Methodology
 The 2002 Healthcare Conference Surviving or Thriving ? 29 September-1 October 2002 Scarman House, The University of Warwick, Coventry.
Vicky Copley, PHE Risk Factor Intelligence
What is a Hypothesis? A hypothesis is a claim (assumption) about the population parameter Examples of parameters are population mean or proportion The.
Descriptive study design
Improving Cancer Outcomes in Camden Dr Lucia Grun 19 March 2014.
Date of download: 5/28/2016 From: Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S.
CT Screening for Lung Cancer vs. Smoking Cessation: A Cost-Effectiveness Analysis Pamela M. McMahon, PhD; Chung Yin Kong, PhD; Bruce E. Johnson; Milton.
Date of download: 5/31/2016 From: Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years: A Comparative Modeling.
Introduction to General Epidemiology (2) By: Dr. Khalid El Tohami.
CHEST 2014; 145(4): 호흡기내과 R3 박세정. Cigarette smoking ㅡ the most important risk factor for COPD in the US. low value of FEV 1 : an independent predictor.
1 Borgan and Henderson: Event History Methodology Lancaster, September 2006 Session 8.1: Cohort sampling for the Cox model.
OVERVIEW OF STUDY DESIGN. COMMUNITY SURVEYS
Population Health Model (POHEM)
More Than Survival: Futility
Review – First Exam Chapters 1 through 5
Presentation transcript:

Do we want a Synthetic or Cross- sectional population approach to simulation modeling?

Overview Opening Questions Simulation approaches Advantages and Challenges –example of OA prevalence –example of BMI How to convert POHEM-OA from CCHS approach to Synthetic? How to convert CRM cancer models from Synthetic to CCHS approach? Discussion

Opening Questions do we want a synthetic or cross-sectional population approach to simulation modeling? do we believe that a model must fit historical data to be useful ? believable ? ( e.g. smoking  lung cancer ) if synthetic –do we insist on reproducing (joint) distributions found in cross-sectional surveys like CCHS 2001 populations? –how high do we want to set the bar? how closely do we need to represent the individuals on CCHS to claim success eg age*sex*province*bmi*smoking*HUI* CC*... –how do we structure validation/calibration to succeed? (incremental) if cross-sectionally initialized population (CCHS) –are we comfortable imputing histories ? (eg smoking) –do we feel more comfortable with our projections? Is one approach or the other more easily communicated to decision- makers? other researchers? Which approach has more face-validity, that could possibly lead to wider acceptance and use?

Simulation Approaches Synthetic Birth Cohort –Early POHEM cancer and HD models Synthetic Multi-cohort from Birth –Lifepaths, POHEM cancer screening –Cancer Risk Management Model CCHS Multi-cohort from Cross-section –POHEM-OA++ –POHEM-PA++ (PHAC) –POHEM-OBESITY (PHAC) ( proposal) –POHEM-HEBIC (PHAC) (proposal) STAR

Synthetic Birth Cohort Age 0 sex province Sub-Models : Initialize risk factors (eg at age 15) Risk factors change as person ages eg. joint distribution of chol * bp * diab * bmi Incidence by age, sex Progression (survival) Outcomes: Lifetime costs Average duration in state LE What-if scenario outcomes: Change in LE Models that use this approach: Early POHEM lung and breast cancer Captures realistic, recent distributions of risk factors for recent period No attempt to reproduce joint % in CCHS 2001

Synthetic Multi-cohort Year of birth … Age … … etc 1872… Projected births Projected immigration Models that use this approach: Lifepaths Early POHEM-CRC, Preventive tamoxifen Cancer Risk Management Model

CCHS Year of birth … Age etc … … … CCHS age, sex, province, education, income, BMI value, smoking, HUI, SROA, … Coherent set of variables for each individual Projected immigration initial value of BMI self-reported in CCHS project BMI : models of change in BMI in individuals from NPHS ( ) Consider BMI: Projected births Models that use this approach: POHEM-OA (BMI, CCORT-AMI, DPORT-Diabetes) POHEM-PA (BMI, HD, Cancer, Diabetes, Mortality)

Synthetic Multi-cohort Year of birth … Age … Projected births Projected immigration 2 3 … … Challenge: initialize BMI (at age 18) Solution: obtain distribution of BMI (at age 18) from various historical data sources (like what we have done for smoking) Challenge: projection of BMI (after age 18) Solution: use the NPHS regression models Remark: not valid across all periods / simplifying assumptions Challenge: not likely to match BMI% in CCHS 2001 Solution: calibration ( no unique solution, arbitrary ) Challenge: joint % of BMI with everything else (smoking, SROA, HUI, age, sex…) Solution: calibration ( no unique solution; very challenging / time consuming) Remark: Is a model useful that does not meet this level of “correctness”? ? ? Consider BMI

CCHS Multi-cohort … … CCHS age, sex, province, education, income, BMI value, smoking, HUI, SROA, … Advantage: Coherent set of variables for each individual Challenge: no (or little) history available on survey Solution: use survey information (eg age at start smoking), other data source, or extrapolate/infer Example: what is progression of OA in prevalent cases? Solution: effectively impute history by using incidence to progression survival curves, draw random point on progression pathway Challenge: self-report data inconsistent with other data sources Example: prevalence of self-reported OA in 2001 is inconsistent with administrative definition of OA prevalence Solution: match (tag) admin OA prevalence to SROA individuals as much as possible Future History Challenge: sharing CCHS file Solution: limit access, use public file Validation: Start with CCHS 2001 and validate against external datasets include CCHS 2003, 2005, 2007… and CHMS 2011 Start model with NPHS 1996… but do we expect NPHS and CCHS to agree? (not a simulation question) Challenge: missing children and youth Solution: use NLSCY, NPHS, (CCHS12+)

How would we convert POHEM-OA from CCHS to Synthetic approach? OA Incidence rates –calibrated to 2001 by age and sex, based on distribution of BMI in CCHS 2001 “reference” rates associated with normal weight –assume reference rates apply in all previous years or apply trend –easy OA Prevalence rates –not required, generated from incidence rates Progression of OA –survival curves still work HUI –initialize HUI to 1.0 at age 0, apply model of change in HUI as it is –unlikely to reproduce distribution of HUI observed in CCHS– calibrate ? BMI –initialize historically (at age 18) –apply models of change in BMI starting at age 18 –unlikely to reproduce 2001 CCHS distribution of BMI –calibrate ? Everything Else –AMI, diabetes, smoking, joint distribution of cardiac factors… –similar issues

How would be convert CRM cancer models into CCHS approach? how do we assign cumulative history of smoking (radon) in 2001? –age at smoking initiation on CCHS? –impute from other survey or data source? –impute from CRM (by current smoker status, sex, province, and others) cancer incidence calibrated to 2005 –could recalibrate to 2001 assign cancer prevalence in 2001 (same challenges as for OA) cancer screening should be transparent (?) treatment conditioned on incidence, progression, so ok what about interprovincial migration, educational dynamics, income dynamics? –needs investigation, probably feasible, possibly quite easy

Discussion do we want a synthetic or cross-sectional population approach to simulation modeling? do we believe that a model must fit historical data to be useful ? believable ? ( e.g. smoking  lung cancer ) if synthetic –do we insist on reproducing (joint) distributions found in cross-sectional surveys like CCHS 2001 populations? –how high do we want to set the bar? how closely do we need to represent the individuals on CCHS to claim success eg age*sex*province*bmi*smoking*HUI* CC*... –how do we structure validation/calibration to succeed? (incremental) if cross-sectionally initialized population (CCHS) –are we comfortable imputing histories ? (eg smoking) –do we feel more comfortable with our projections? Is one approach or the other more easily communicated to decision- makers? other researchers? Which approach has more face-validity, that could possibly lead to wider acceptance and use?